home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
 
  HUM-MOLGEN -> Events -> Meetings and Conferences
Search  -  prev / next
 
 

How EHR Data Can be Used to Advance Guideline-directed Care

 
  October 15, 2024  
     
 
Xtalks, Online
2024-12-05


Understanding post-approval performance of medical devices is inherently challenging whether through randomized trials or real-world data (RWD). Device researchers are often limited to studying broad device classes or setting up agreements with individual providers or health systems to collect necessary data.

In this webinar, the expert speakers will have an in-depth discussion on advancing medical device performance and patient outcomes using complete electronic health records (EHR) data. They will share insights into their partnership to address gaps in real-world device performance data, foster innovation, promote health equity and inform clinical guidelines.

The understanding of post-approval medical device performance can be revolutionized by providing access to complete EHR data, including device-level data, clinical notes and medical images, for more than 100 million patients. These data can be standardized to a common model, linked across health systems and enriched with social determinants of health, mortality and claims data for a holistic view of patient journeys.

In this webinar, the speakers highlight published research using data on device utilization and safety for peripheral artery disease and pulmonary embolism as well as discuss how future research and research collaborations can be conducted using standardized data models.

Register for this webinar today to discover how complete EHR data are advancing medical device performance and improving patient outcomes.

Keywords: Clinical Research, CRO, Digital Health, Medical Devices, Market Access, Clinical Data, Clinical Development, HEOR, RWE, Commercialization/HEOR/Market Access, RWD
 
 
Organized by: Xtalks
Invited Speakers: Dr. Ryan Ahern, Co-Founder and Chief Medical Officer, Truveta
Dr. Michael R. Jaff, Chief Medical Officer and Vice-President of Clinical Affairs, Technology and Innovation, Peripheral Interventions, Boston Scientific Corporation
 
Deadline for Abstracts: 2024-12-05
 
Registration: Free Registration
E-mail: tristan@xtalks.com
 
 
   
 
home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
 
 
 

Generated by meetings and positions 5.0 by Kai Garlipp
WWW: Kai Garlipp, Frank S. Zollmann.
7.0 © 1995-2024 HUM-MOLGEN. All rights reserved. Liability, Copyright and Imprint.